{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:34:00Z","timestamp":1790728440008,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009858","name":"Gabrielle's Angel Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DP5OD023088"],"award-info":[{"award-number":["DP5OD023088"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5T32AI00753223"],"award-info":[{"award-number":["5T32AI00753223"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5R01AI25563-05"],"award-info":[{"award-number":["5R01AI25563-05"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.celrep.2023.112147","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T23:59:14Z","timestamp":1677110354000},"page":"112147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["IL-18BP mediates the balance between protective and pathological immune responses to Toxoplasma gondii"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7764-6000","authenticated-orcid":false,"given":"Joseph T.","family":"Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orr-El","family":"Weizman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Aldridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey A.","family":"Shallberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Eberhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Lanzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon","family":"Wasche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Huck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3092-1428","authenticated-orcid":false,"given":"Christopher A.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2023.112147_bib1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1074-7613(00)80543-9","article-title":"Defective NK cell activity and Th1 response in IL-18-deficient mice","volume":"8","author":"Takeda","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2023.112147_bib2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/378088a0","article-title":"Cloning of a new cytokine that induces IFN-gamma production by T\u00a0cells","volume":"378","author":"Okamura","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112147_bib3","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.4049\/jimmunol.157.9.3967","article-title":"IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones","volume":"157","author":"Tsutsui","year":"1996","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112147_bib4","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/iai.57.2.590-595.1989","article-title":"Endotoxin-induced serum factor that stimulates gamma interferon production","volume":"57","author":"Nakamura","year":"1989","journal-title":"Infect. Immun."},{"key":"10.1016\/j.celrep.2023.112147_bib5","first-page":"4557","article-title":"Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma","volume":"57","author":"Micallef","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2023.112147_bib6","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/eji.1830260736","article-title":"Interferon-\u03b3-inducing factor enhances T helper 1 cytokine production by stimulated human T\u00a0cells: synergism with interleukin-12 for interferon-\u03b3 production","volume":"26","author":"Micallef","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2023.112147_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4049\/jimmunol.169.1.323","article-title":"Contribution of IL-18 to Th1 response and host defense against infection by Mycobacterium tuberculosis : a comparative study with IL-12p40","volume":"169","author":"Kinjo","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112147_bib8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.immuni.2017.03.016","article-title":"NAIP-NLRC4 inflammasomes coordinate intestinal epithelial cell expulsion with eicosanoid and IL-18 release via activation of caspase-1 and -8","volume":"46","author":"Rauch","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2023.112147_bib9","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.cell.2020.02.004","article-title":"Enteric nervous system-derived IL-18 orchestrates mucosal barrier immunity","volume":"180","author":"Jarret","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2023.112147_bib10","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2007807118","article-title":"The intestinal parasite Cryptosporidium is controlled by an enterocyte intrinsic inflammasome that depends on NLRP6","volume":"118","author":"Sateriale","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2023.112147_bib11","article-title":"Crosstalk between enterocytes and innate lymphoid cell drives early IFN-\u03b3-mediated control of Cryptosporidium","author":"Gullicksrud","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2023.112147_bib12","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.4049\/jimmunol.163.5.2821","article-title":"Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice","volume":"163","author":"Wei","year":"1999","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112147_bib13","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.jaci.2016.10.022","article-title":"Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition","volume":"139","author":"Canna","year":"2017","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.celrep.2023.112147_bib14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1023\/A:1006641630904","article-title":"Elevation of IL-18 in human sepsis","volume":"20","author":"Grobmyer","year":"2000","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.celrep.2023.112147_bib15","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.4049\/jimmunol.162.12.7322","article-title":"Virus infection activates IL-1 and IL-18 production in human macrophages by a caspase-1-dependent pathway 1","volume":"162","author":"Pirhonen","year":"1999","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112147_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/meth.1999.0837","article-title":"Interleukin-18","volume":"19","author":"Dinarello","year":"1999","journal-title":"Methods"},{"key":"10.1016\/j.celrep.2023.112147_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1074-7613(00)80013-8","article-title":"Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response","volume":"10","author":"Novick","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2023.112147_bib18","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nrmicro2858","article-title":"Modulation of innate immunity by Toxoplasma gondii virulence effectors","volume":"10","author":"Hunter","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.celrep.2023.112147_bib19","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1073\/pnas.90.13.6115","article-title":"Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts","volume":"90","author":"Gazzinelli","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2023.112147_bib20","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1128\/iai.62.7.2818-2824.1994","article-title":"Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha","volume":"62","author":"Hunter","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.celrep.2023.112147_bib21","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.4049\/jimmunol.153.6.2533","article-title":"Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii","volume":"153","author":"Gazzinelli","year":"1994","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112147_bib22","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.4049\/jimmunol.138.11.3737","article-title":"Depletion of T-4+ lymphocytes with monoclonal antibody reactivates toxoplasmosis in the central nervous system: a model of superinfection in AIDS","volume":"138","author":"Vollmer","year":"1987","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112147_bib23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4049\/jimmunol.149.1.175","article-title":"Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii","volume":"149","author":"Gazzinelli","year":"1992","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112147_bib24","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1128\/IAI.00098-06","article-title":"Organ- and disease-stage-specific regulation of Toxoplasma gondii-specific CD8-T-cell responses by CD4 T\u00a0cells","volume":"74","author":"L\u00fctjen","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.celrep.2023.112147_bib25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/eji.200939705","article-title":"IL-33 receptor (T1\/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii","volume":"40","author":"Jones","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2023.112147_bib26","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1038\/s41467-020-17491-z","article-title":"Gasdermin-D-dependent IL-1\u03b1 release from microglia promotes protective immunity during chronic Toxoplasma gondii infection","volume":"11","author":"Batista","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2023.112147_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009027","article-title":"Astrocytes promote a protective immune response to brain Toxoplasma gondii infection via IL-33-ST2 signaling","volume":"16","author":"Still","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2023.112147_bib28","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.65614","article-title":"Il-33 promotes innate lymphoid cell-dependent ifn-\u03b3 production required for innate immunity to toxoplasma gondii","volume":"10","author":"Clark","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.celrep.2023.112147_bib29","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.4049\/jimmunol.155.9.4347","article-title":"IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T\u00a0cell-independent mechanism of resistance against intracellular pathogens","volume":"155","author":"Hunter","year":"1995","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112147_bib30","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.4049\/jimmunol.166.9.5720","article-title":"A heritable defect in IL-12 signaling in B10.Q\/J mice. II. Effect on acute resistance to toxoplasma gondii and rescue by IL-18 treatment","volume":"166","author":"Yap","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112147_bib31","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1002\/eji.200424993","article-title":"Both IL-12 and IL-18 contribute to small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii , but IL-12 is dominant over IL-18 in parasite control","volume":"34","author":"Vossenk\u00e4mper","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2023.112147_bib32","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1073\/pnas.0706663105","article-title":"T cell expression of MyD88 is required for resistance to Toxoplasma gondii","volume":"105","author":"LaRosa","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2023.112147_bib33","doi-asserted-by":"crossref","first-page":"6932","DOI":"10.1128\/IAI.68.12.6932-6938.2000","article-title":"Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii","volume":"68","author":"Cai","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.celrep.2023.112147_bib34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1043-4666(03)00013-9","article-title":"IL-10 fails to inhibit the production of IL-18 in response to inflammatory stimuli","volume":"21","author":"Zediak","year":"2003","journal-title":"Cytokine"},{"key":"10.1016\/j.celrep.2023.112147_bib35","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.4049\/jimmunol.2000168","article-title":"Production of IL-18 binding protein by radiosensitive and radioresistant cells in CpG-induced macrophage activation syndrome","volume":"205","author":"Harel","year":"2020","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112147_bib72","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1128\/IAI.00425-12","article-title":"The Toxoplasma gondii peptide AS15 elicits CD4 T cells that can control parasite burden","volume":"80","author":"Grover","year":"2012","journal-title":"Infect Immun."},{"key":"10.1016\/j.celrep.2023.112147_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000815","article-title":"Differential Regulation of Effector- and Central-Memory Responses to Toxoplasma gondii Infection by IL-12 Revealed by Tracking of Tgd057-Specific CD8+ T Cells","volume":"6","author":"Wilson","year":"2010","journal-title":"PLOS Pathogens"},{"key":"10.1016\/j.celrep.2023.112147_bib36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41586-020-2422-6","article-title":"IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy","volume":"583","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112147_bib37","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.185.7.1261","article-title":"Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii","volume":"185","author":"Scharton-Kersten","year":"1997","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2023.112147_bib38","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1084\/jem.189.7.1083","article-title":"Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-\u03b3- and tumor necrosis factor (TNF)-\u03b1- dependent host resistance to the intracellular pathogen, Toxoplasma gondii","volume":"189","author":"Yap","year":"1999","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2023.112147_bib39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.immuni.2016.06.013","article-title":"Continuous effector CD8\u00a0+ T\u00a0cell production in a controlled persistent infection is sustained by a proliferative intermediate population","volume":"45","author":"Chu","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2023.112147_bib40","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.immuni.2016.10.018","article-title":"The chemokine receptor CX3CR1 defines three antigen-experienced CD8 T\u00a0cell subsets with distinct roles in immune surveillance and homeostasis","volume":"45","author":"Gerlach","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2023.112147_bib41","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.immuni.2006.09.007","article-title":"A distal conserved sequence element controls Ifng gene expression by T\u00a0cells and NK cells","volume":"25","author":"Hatton","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2023.112147_bib42","doi-asserted-by":"crossref","first-page":"e1213","DOI":"10.1128\/mBio.01117-13","article-title":"Dual role for inflammasome sensors NLRP1 and NLRP3 in murine resistance to toxoplasma gondii","volume":"5","author":"Gorfu","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.celrep.2023.112147_bib43","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1128\/IAI.01170-13","article-title":"NLRP1 is an inflammasome sensor for toxoplasma gondii","volume":"82","author":"Ewald","year":"2014","journal-title":"Infect. Immun."},{"key":"10.1016\/j.celrep.2023.112147_bib44","doi-asserted-by":"crossref","first-page":"e100926","DOI":"10.15252\/embj.2018100926","article-title":"Human GBP 1 is a microbe-specific gatekeeper of macrophage apoptosis and pyroptosis","volume":"38","author":"Fisch","year":"2019","journal-title":"EMBO J."},{"key":"10.1016\/j.celrep.2023.112147_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108008","article-title":"Human GBP1 differentially targets Salmonella and toxoplasma to license recognition of microbial ligands and caspase-mediated death","volume":"32","author":"Fisch","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2023.112147_bib46","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1006\/bbrc.1999.2064","article-title":"Interferon-\u03b3 mediates gene expression of IL-18 binding protein in nonleukocytic cells","volume":"267","author":"M\u00fchl","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.celrep.2023.112147_bib47","doi-asserted-by":"crossref","first-page":"16957","DOI":"10.1073\/pnas.262663399","article-title":"The promoter of IL-18 binding protein: activation by an IFN-\u03b3-induced complex of IFN regulatory factor 1 and CCAAT\/enhancer binding protein \u03b2","volume":"99","author":"Hurgin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2023.112147_bib48","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.3128869","article-title":"Interferon-\u03b3: the major mediator of resistance against toxoplasma gondii","volume":"240","author":"Suzuki","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112147_bib49","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1084\/jem.158.3.670","article-title":"Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity","volume":"158","author":"Nathan","year":"1983","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2023.112147_bib50","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cyto.2015.01.021","article-title":"IL-18 contributes to susceptibility to Leishmania amazonensis infection by macrophage-independent mechanisms","volume":"74","author":"Sousa","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.celrep.2023.112147_bib51","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.4049\/jimmunol.164.11.5890","article-title":"Genetically resistant mice lacking IL-18 gene develop Th1 response and control cutaneous Leishmania major infection","volume":"164","author":"Monteforte","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112147_bib52","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/eji.200939583","article-title":"A role for IL-18 in protective immunity against Mycobacterium tuberculosis","volume":"40","author":"Schneider","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2023.112147_bib53","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1128\/IAI.67.5.2585-2589.1999","article-title":"Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice","volume":"67","author":"Sugawara","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.celrep.2023.112147_bib54","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/jeu.12164","article-title":"IL-18 cytokine levels modulate innate immune responses and cryptosporidiosis in mice","volume":"62","author":"Bedi","year":"2015","journal-title":"J.\u00a0Eukaryot. Microbiol."},{"key":"10.1016\/j.celrep.2023.112147_bib55","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4049\/jimmunol.164.1.371","article-title":"IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN-\u03b3 and nitric oxide synthetase 2","volume":"164","author":"van Den Broek","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112147_bib56","doi-asserted-by":"crossref","first-page":"9960","DOI":"10.1128\/JVI.77.18.9960-9968.2003","article-title":"Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity","volume":"77","author":"Reading","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2023.112147_bib57","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00281-012-0339-3","article-title":"Immune response and immunopathology during toxoplasmosis","volume":"34","author":"Dupont","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.celrep.2023.112147_bib58","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.20190669","article-title":"Inherited IL-18BP deficiency in human fulminant viral hepatitis","volume":"216","author":"Belkaya","year":"2019","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2023.112147_bib59","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1158\/1078-0432.CCR-06-0121","article-title":"Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancer","volume":"12","author":"Robertson","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2023.112147_bib60","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/cncr.24100","article-title":"A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma","volume":"115","author":"Tarhini","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.celrep.2023.112147_bib61","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fimmu.2012.00239","article-title":"Protection from inflammatory organ damage in a murine model of hemophagocytic lymphohistiocytosis using treatment with IL-18 binding protein","volume":"3","author":"Chiossone","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2023.112147_bib62","doi-asserted-by":"crossref","first-page":"9971","DOI":"10.1073\/pnas.1203543109","article-title":"Regulation of innate CD8+ T-cell activation mediated by cytokines","volume":"109","author":"Freeman","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2023.112147_bib63","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1128\/IAI.01722-14","article-title":"Complex immune cell interplay in the gamma interferon response during toxoplasma gondii infection","volume":"82","author":"Sturge","year":"2014","journal-title":"Infect. Immun."},{"key":"10.1016\/j.celrep.2023.112147_bib64","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.4049\/jimmunol.1500690","article-title":"Flt3 ligand is essential for survival and protective immune responses during toxoplasmosis","volume":"195","author":"Dupont","year":"2015","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112147_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062889","article-title":"IL-21 is required for optimal antibody production and T\u00a0cell responses during chronic toxoplasma gondii infection","volume":"8","author":"Stumhofer","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2023.112147_bib66","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1084\/jem.20122300","article-title":"CD4+ T\u00a0cells are trigger and target of the glucocorticoid response that prevents lethal immunopathology in toxoplasma infection","volume":"210","author":"Kugler","year":"2013","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.celrep.2023.112147_bib67","doi-asserted-by":"crossref","first-page":"798","DOI":"10.4049\/jimmunol.157.2.798","article-title":"In The absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T\u00a0cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha","volume":"157","author":"Gazzinelli","year":"1996","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112147_bib68","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1074-7613(03)00300-5","article-title":"The IL-27r (WSX-1) is required to suppress T\u00a0cell hyperactivity during infection","volume":"19","author":"Villarino","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2023.112147_bib69","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4049\/jimmunol.131.1.458","article-title":"Augmentation of NK cell activity by soluble and particulate fractions of Toxoplasma gondii","volume":"131","author":"Hauser","year":"1983","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112147_bib70","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.4049\/jimmunol.158.5.2285","article-title":"The role of the CD28\/B7 interaction in the regulation of NK cell responses during infection with Toxoplasma gondii","volume":"158","author":"Hunter","year":"1997","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112147_bib71","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1128\/iai.59.5.1709-1715.1991","article-title":"Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli","volume":"59","author":"Wherry","year":"1991","journal-title":"Infect. Immun."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124723001584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124723001584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:57:58Z","timestamp":1778842678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124723001584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2211124723001584"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2023.112147","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-18BP mediates the balance between protective and pathological immune responses to Toxoplasma gondii","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2023.112147","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"112147"}}